Vaccine Alliance

Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.

The Gavi vaccine alliance is in talks with Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told news agency Reuters on Thursday.

Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.

The GAVI vaccine alliance hopes the Serum Institute of India (SII) will resume exports of the AstraZeneca COVID-19 vaccine from this quarter, it told Reuters, which would be earlier than an "end of this year" forecast by the Indian company.

COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.

US has so far contributed $2 billion to GAVI for COVAX facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

The Covax global vaccine-sharing programme said Thursday it needs $2.0 billion in additional funding by the beginning of June in order to boost coronavirus inoculation programmes in lower-income countries.

Nissan India announced that it contributed over Rs. 6.5 crore to local communities and the Tamil Nadu State Disaster Management Authority (SDMA) for COVID-19 relief.

Gavi, a global alliance on vaccines, on Friday said that India would receive between 190 and 250 million fully subsidised doses of COVID-19 vaccine and funds up to USD 30 million for urgent technical assistance and cold chain equipment.

With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.

India, which is experiencing a sudden rise in number of COVID-19 cases, is now likely to make available a smaller number of vaccines to the rest of the world, the head of the Global Alliance for Vaccines and Immunisation has said.

Pakistan will soon get 'made-in-India' coronavirus vaccinesunder the United Global Alliance for Vaccines and Immunization or GAVI, a public-private global health partnership to increase access to immunisation in poor countries.

India has urged the United States, Japan and Australia to invest in its vaccine production capacity, a government source told news agency Reuters, as the so-called Quad alliance tries to counter China's growing vaccine diplomacy.

Days after joining the World Health Organisation's (WHO) COVAX alliance to equitably distribute COVID-19 vaccines across the world, China has stepped up the usage of its coronavirus vaccines to three more cities for urgent use.

Serum Institute of India said on Tuesday it would get a further $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make an additional 100 million COVID-19 vaccine doses for India and other low- and middle-income countries next year.

Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.

The Gavi vaccine alliance is in talks with Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told news agency Reuters on Thursday.

Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.

The GAVI vaccine alliance hopes the Serum Institute of India (SII) will resume exports of the AstraZeneca COVID-19 vaccine from this quarter, it told Reuters, which would be earlier than an "end of this year" forecast by the Indian company.

COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.

US has so far contributed $2 billion to GAVI for COVAX facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

The Covax global vaccine-sharing programme said Thursday it needs $2.0 billion in additional funding by the beginning of June in order to boost coronavirus inoculation programmes in lower-income countries.

Nissan India announced that it contributed over Rs. 6.5 crore to local communities and the Tamil Nadu State Disaster Management Authority (SDMA) for COVID-19 relief.

Gavi, a global alliance on vaccines, on Friday said that India would receive between 190 and 250 million fully subsidised doses of COVID-19 vaccine and funds up to USD 30 million for urgent technical assistance and cold chain equipment.

With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.

India, which is experiencing a sudden rise in number of COVID-19 cases, is now likely to make available a smaller number of vaccines to the rest of the world, the head of the Global Alliance for Vaccines and Immunisation has said.

Pakistan will soon get 'made-in-India' coronavirus vaccinesunder the United Global Alliance for Vaccines and Immunization or GAVI, a public-private global health partnership to increase access to immunisation in poor countries.

India has urged the United States, Japan and Australia to invest in its vaccine production capacity, a government source told news agency Reuters, as the so-called Quad alliance tries to counter China's growing vaccine diplomacy.

Days after joining the World Health Organisation's (WHO) COVAX alliance to equitably distribute COVID-19 vaccines across the world, China has stepped up the usage of its coronavirus vaccines to three more cities for urgent use.

Serum Institute of India said on Tuesday it would get a further $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make an additional 100 million COVID-19 vaccine doses for India and other low- and middle-income countries next year.